AdvisorShares Investments LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1425930
BETHESDA, MD
Position in TEVA
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,097,301
-$51,227 QoQ
Shares Held
36,431
-1.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AdvisorShares Investments LLC holds $8,678,668 across 12 Drug Manufacturers - Specialty & Generic names. TEVA ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRON |
Cronos Group Inc.
|
532,394 | $1,336,308 | |
| 2 | OGI |
Organigram Global Inc.
|
947,440 | $1,269,569 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
36,431 | $1,097,301 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,170 | $944,575 | |
| 5 | ALKS |
Alkermes plc.
|
26,369 | $932,407 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
17,453 | $902,145 | |
| 7 | ACB |
Aurora Cannabis Inc
|
171,110 | $559,529 | |
| 8 | ROMJF |
Rubicon Organics Inc.
|
1,498,936 | $535,120 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,097,301 | 36,431 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,148,528 | 36,800 | Shares | Sole | 2026-02-10 | |
| 2025-03-31 | $663,707 | 43,182 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $632,459 | 28,696 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $593,146 | 32,916 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||